Antibody titers to pseudorabies virus in piglets immunized with gIII deleted pseudorabies vaccine in a pseudorabies infected herd

The decrease in titer of PRV antibodies in serum was evaluated at 10, 37, 67, 109 and 173 days of age in 16 non-vaccinated pigs and 43 pigs vaccinated at 3, 67 and 80 days of age with a modified live TK/gIII gene deleted pseudorabies virus (PRV) vaccine. Serum samples were analyzed for antibodies to...

Full description

Saved in:
Bibliographic Details
Published inVeterinary microbiology Vol. 42; no. 4; pp. 341 - 348
Main Authors Elvinger, François, Reeves, David E., Pursell, Alfred R., Cole, John R., Liauw, Hardi
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 01.12.1994
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The decrease in titer of PRV antibodies in serum was evaluated at 10, 37, 67, 109 and 173 days of age in 16 non-vaccinated pigs and 43 pigs vaccinated at 3, 67 and 80 days of age with a modified live TK/gIII gene deleted pseudorabies virus (PRV) vaccine. Serum samples were analyzed for antibodies to PRV by the serum-virus neutralization test (SN), a commercial competitive ELISA (CELISA), and the CELISA OMNIMARK PRV differential (OMD) diagnostic kit. At 10 days of age, all pigs had SN titers ≥ 1:4 and were CELISA+/OMD+, indicating circulating antibodies to field strains of PRV. At 109 days, all non-vaccinated pigs had SN titers < 1:4. Forty-five percent of vaccinated pigs had SN titers ≥ 1:4, 56% were CELISA positive and most were CELISA+/OMD−, indicating antibodies due to vaccination. At 24 weeks of age, all pigs had SN titers ≥ 1:4 and were CELISA+/OMD+ due to exposure to field strains. Although circulating maternal antibodies interfere with the development of active immunity, vaccination at 3 days of age resulted in detectable antibodies by 67 days of age, and a limited immune response could be measured at 109 days of age.
Bibliography:L73
9502010
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0378-1135
1873-2542
DOI:10.1016/0378-1135(94)90065-5